Search Results - "Olena, Kolesnik"

Refine Results
  1. 1
  2. 2
  3. 3

    Cost-effectiveness of colorectal cancer screening in Ukraine by Melnitchouk, Nelya, Soeteman, Djøra I, Davids, Jennifer S, Fields, Adam, Cohen, Joshua, Noubary, Farzad, Lukashenko, Andrey, Kolesnik, Olena O, Freund, Karen M

    Published in Cost effectiveness and resource allocation (07-06-2018)
    “…Colorectal cancer is one of the most common cancers worldwide and is associated with high mortality when detected at a later stage. There is a paucity of…”
    Get full text
    Journal Article
  4. 4

    VESTIBULAR DYSFUNCTIONS IN CHRONIC BRAIN ISCHEMIA IN THE POST COVID PERIOD by Stoyanov, Alexander N, Mashchenko, Serhii S, Kalashnikov, Valeriy I, Vastyanov, Rooslan S, Pulyk, Alexander R, Andreeva, Tamara O, Kolesnik, Olena O

    Published in Wiadomości lekarskie (1960) (2023)
    “…The aim: The aim of the study is the clinical-pathogenetic reasoning of vestibular dysfunctions (VD) development against the background of chronic brain…”
    Get more information
    Journal Article
  5. 5

    8-hydroxy-deoxyguanosine as an independent prognostic factor in patients with metastatic colorectal cancer by BURLAKA, Anton, RUDIUK, Tymur, BURLAKA, Anatoly, KOLESNIK, Olena, HORBATIUK, Iryna B.

    “…Introduction. Surgical injury can stimulate tumor growth in metastatic colorectal cancer (mCRC), due to mitochondrial dysfunction. The objective of the study…”
    Get full text
    Journal Article
  6. 6

    Leiomyosarcoma of the Rectum as a Radiation-Induced Second Malignancy after Cervical Cancer Treatment: Case Report with Review of the Literature by Volk, Maryna O., Lagoda, Natalia N., Kolesnik, Olena O., Makhmudov, Dmytro E.

    “…Background. Incidence of cervical cancer among women of reproductive age still remains significantly high. In regard to prognostic features and risk factors,…”
    Get full text
    Journal Article
  7. 7

    Parenchyma sparing multicomponent liver resection strategy for multiple bilobar synchronous colorectal cancer metastasis by Burlaka, Anton Anatoliyovych, Kolesnik, Olena Oleksandrivna

    Published in Clinical case reports (01-04-2020)
    “…A two‐stage multicomponent parenchymal sparing surgical strategy (anatomical extended on left hepatic vein 2‐nd segment liver resection and R1vascular…”
    Get full text
    Journal Article
  8. 8

    A method of reconstruction after pancreaticoduodenectomy for pancreatic malignancies in very young children: Two cases reports by Inviati, Angela, Martino Marino, Marco Vito, Kolesnik, Olena, Klimnuk, Grigoriy, Shabat, Galyna, Lukashenko, Andrey, Gulotta, Gaspare, Bonventre, Sebastiano

    Published in Journal of pediatric surgery case reports (01-08-2016)
    “…Abstract Pancreatic tumors are very rare diseases in very young children. Most information about those diseases in children was published in cases reports. Due…”
    Get full text
    Journal Article
  9. 9

    Colorectal Cancer in Ukraine: Regional Disparities and National Trends in Incidence, Management, and Mortality by Melnitchouk, Nelya, Shabat, Galyna, Lu, Pamela, Lyu, Heather, Scully, Rebecca, Leung, Krystle, Jarman, Molly, Lukashenko, Andrey, Kolesnik, Olena O, Goldberg, Joel, Davids, Jennifer S, Bleday, Ronald

    Published in Journal of global oncology (24-10-2018)
    “…The incidence of colorectal cancer (CRC) is increasing worldwide, and the greatest increase is in low- to middle-income countries, such as Ukraine. Better…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Resection and simultaneous reconstruction of the infrarenal aorta and inferior vena cava (case report) by Burlaka, Anton, Vasiliev, Oleg, Kolesnik, Olena

    Published in Polski przeglad chirurgiczny (13-03-2019)
    “…A non-standard surgicall approach in malignant retroperitoneal tumor treatment was used, which includes simultaneous resection and reconstruction of the…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial by Wakelee, Heather, Lee, Se-Hoon, Dooms, Christophe, Majem, Margarita, Novello, Silvia, Arunachalam, Ashwini, Keller, Steven M, Gao, Shugeng, Afanasyev, Sergey, Ahmed, Samreen, Alekshun, Todd, Alves, Gustavo, Anderson, Ian, Arkhipov, Alexander, Arora, Arvind, Berceanu-Ion, Radu, Bernabe Caro, Reyes, Bondarenko, Igor, Brocca, Carlos, Bryl, Maciej, Carcereny, Enric, Chaft, Jamie, Chaves, Fabio, Chen, Jun, Chiang, Chi-Lu, Ciurescu, Ioana, Coetzee, Corlia, Collins, Dearbhaile, Costas, Kimberly, Costin, Dan, Cronemberger, Eduardo Henrique, de Paiva Junior, Tadeu, Delmonte, Angelo, Demedts, Ingel, Dooms, Christophe, Dutra, Carolina, Ernani, Vinicius, Faehling, Martin, Ferrara, Roberto, Frohling, Klaus-Peter, Furqan, Muhammad, Gianni, Luca, Gilli, Marina, Goranov, Bojidar, Guarino, Michael, Halmos, Balazs, Ikeda, Norihiko, Intagliata, Salvatore, Jain, Kirti, Karaseva, Nina, Kaywin, Paul, Keresztes, Roger, Kolesnik, Oleksii, Kristedja, Timothy, Levenko, Oleh, Li, Shanqing, Liao, Bin-Chi, Lou, Yan Yan, Luft, Alexander, Ma, Shaohua, Majem Tarruella, Margarita, Makles, Krytsyna, Martinengo, Gaston, Martinez Marti, Alex, Matias, Danielli, Mazieres, Julien, Molina, Julian, Muto, Satoshi, Nadal Alforja, Ernest, Nesterova, Alfiya, Novello, Silvia, O'Brien, Mary, Ogliari, Francesca, Pastor, Andrea, Pollock, Theodore, Reinacher-Schick, Anke, Ritgen, Mathias, Ruff, Paul, Saji, Hisashi, Sardenberg, Rodrigo, Scheusan, Roxana, Serke, Monika, Shio, Yutaka, Siegel, Robert, Sokur, Iryna, Stencel, Katarzyna, Sugio, Kenji, Suzuki, Hiroyuki, Takamochi, Kazuya, Tan, Lijie, Tatangelo, Marcelo, Thiberville, Luc, Tsai, Chen-Liang, Ungureanu, Andrei, Vansteenkiste, Johan, Wang, Wenxiang, Wirtz, Hubert, Wong, Mark, Yang, Yue, Zhang, Lanjun

    Published in The Lancet (British edition) (28-09-2024)
    “…At the first interim analysis of the KEYNOTE-671 trial, adding perioperative pembrolizumab to neoadjuvant chemotherapy significantly improved event-free…”
    Get full text
    Journal Article
  19. 19
  20. 20